Through an in vivo study, we confirmed that injecting M-HGF suppressed the expression of TGF-β, α-SMA, and type III collagen, consequently suppressing the progression of peritoneal fibrosis while maintaining peritoneal function. The gene discussed is ACTA1; the disease is Peritoneal Fibrosis.